Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Neuropathic Pain Market Size From 2025 to 2034?

In the past few years, the market size for neuropathic pain has been showing robust growth. The market which is valued at $5.35 billion in 2024, is projected to increase to $5.78 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.9%. This escalation in the market during the historical era is due to the heightened demand for neuropathic pain medications, the prevalence of chronic pain, rising demand for prescribed therapies, and government interventions.

Forecasts indicate that the neuropathic pain industry is poised for significant expansion in the coming years. The predicted growth will propel the market to a worth of $7.78 billion by 2029, representing a compound annual growth rate (CAGR) of 7.7%. Varying factors such as increased understanding of neuropathic pain, an aging global populace, a well-developed healthcare sector, and availability of pain treatments are contributing to this anticipated growth. The time span of the forecast sees trends such as improved diagnostic processes, advancements in pain management techniques, evolution in medical research, the approval of new medications, and decisive strategic initiatives.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12922&type=smp

What External and Internal Drivers Are Contributing to the Growth of theNeuropathic Pain Market?

The neuropathic pain market is anticipated to expand due to the increasing incidence of chronic pain. Chronic pain is a long-lasting pain that continues beyond the anticipated healing period of an injury or illness and normally persists for at least three to six months or longer. The escalating occurrence of chronic pain, inclusive of neuropathic conditions, necessitates effective therapies, thus stimulating research, creativity, and funds into better therapeutic solutions to improve symptom mitigation and life quality. For instance, the Scottish Health Survey 2022, issued by the Scotland-based Scottish Government, stated in December 2023 that in 2022, over a third (38%) of Scotland’s adult population suffered from pain or discomfort lasting for three months or longer, with a higher rate among women (43%) compared to men (33%). As such, the neuropathic pain market’s expansion is driven by the increased incidence of chronic pain.

What Segment Types Define the Neuropathic Pain Market Structure?

The neuropathic painmarket covered in this report is segmented –

1) By Treatment: Medications; Multimodal Therapy

2) By Diagnosis: Imaging; Blood Tests And Physical Examination

3) By Indication: Diabetic Neuropathy; Spinal Stenosis; Chemotherapy-Induced Peripheral Neuropathy; Other Indications

4) By End User: Hospitals; Clinics; Home Healthcare; Ambulatory Surgical Centers; Other End Users

Subsegments:

1) By Medications: Anticonvulsants; Antidepressants; Opioids; Topical Treatments; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

2) By Multimodal Therapy: Combination Of Medications; Physical Therapy; Psychological Therapy; Lifestyle Modifications; Complementary Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12922&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Neuropathic Pain Market?

North America was the largest region in the neuropathic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Neuropathic Pain Market?

Numerous leading firms in the neuropathic pain sector are embracing the use of artificial intelligence to enable advanced diagnosis, personalized treatment, real-time patient monitoring, drug development, and data-backed insights, all with the goal of improving patient results and optimizing pain management strategies. For example, Nevro Corp., a medical device company based in the United States, unveiled the Senza HFX iQ spinal cord stimulation (SCS) system in March 2023. This cutting-edge technology utilizes artificial intelligence to individualize pain management for each patient. The system, including the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger, and HFX App, is architected to address non-surgical back pain and painful diabetic neuropathy by adapting to patients’ reactions and inputs. It operates on a unique algorithm derived from expansive patient data and enables patients to modify their pain relief regime via an app on their smartphones. The system’s digital setup allows for data gathering and potential updates. Aiming to boost pain relief through uniformity and personalization, the technology represents a notable progression in SCS therapy.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

What Is the Definition of the Neuropathic Pain Market?

Neuropathic pain is chronic pain caused by damage or dysfunction in the nervous system and characterized by burning, tingling, shooting, or electric shock-like sensations. Neuropathic pain can be challenging to treat and may be caused by nerve injuries, diabetes, multiple sclerosis, nerve compression, neural degeneration and central nervous system disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12922

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model